COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People
Adult
Male
Supplementary Information
Adolescent
330
https://cdn.jamanetwork.com/ama/content_public/journal/psych/0/yoi240050supp2_prod_1723059057.8842.pdf?Expires=1728984774&Signature=zKNTzmA-xusbyA6-FtD1lyTHlcQBdZgJPo2oM3RMCAvjcdWFnJso2AjfXR-IPyUjMWtN1cqwB9A9J8mz-wyxiyQF5ey65XlA5u-TtGQZ6He72F~RKZ3M2tHnF6YAodlZTvEy1KXhPnCkAtjGKeXZJ3VPkZW0dWTuM3RTO0ZVT0wqkjf5wecWecq2cp8oc50uLyxqX0GNziA4AlsbCz0pth6xbT3GnU1i5ittzkiwN5XB-2Ttwjo9Q0eQFjNpF0Ibd53H1ATqUuMvOi~0EracVrHUC-UL1sBxgZmnD1OjLw4KbWGUzdjyzlAHuFJE7vbDfq67zRkk3c7xK63QQj3f8Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
610
R Medicine (General)
613
Cohort Studies
Young Adult
03 medical and health sciences
0302 clinical medicine
SDG 3 - Good Health and Well-being
80 and over
https://cdn.jamanetwork.com/ama/content_public/journal/psych/0/yoi240050supp3_prod_1723059057.8903.pdf?Expires=1728984774&Signature=KNsAamjYX5LYVlJ~Y4nSR8Srham04bXYAVVVD2jFjaVA5QDO0eAePonRKMiNXk-UqZ2TqpINnWcJ1DtsKKzSNeMkq9ganJRRWNeupApQu6mGZkGodO5sglGyMW8POw~XWWfbxaQQEfiG3FZ0dXk8evha2E4NfLmVemmvQR6OlS5zHygvGFZynHh80OifehVeB-DZSrS4kiOk75tLIjmw6y7vtcs6r4hKORQMV7~mUmZrCjXYX-7kSKZbOUJ3xY2UgcbeA9Qqys4x~y19g7P4jN-Xn2O3UH06nZv7QHv-rB8dFWGAavxbqgBIaN-qbdY6I9reIlIwm7tc67k23k2YAA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
Humans
England/epidemiology
Aged
COVID-19 Vaccines/administration & dosage
COVID-19/epidemiology
Original Investigation
SARS-CoV-2
Middle Aged
https://cdn.jamanetwork.com/ama/content_public/journal/psych/0/yoi240050supp1_prod_1723059057.74559.pdf?Expires=1728984774&Signature=3wu-yX9C8MUyZJa0vgmBiQUzH3MER8tbLEZokx6Af1EmA9U2Ju4~i30ABlkz3fpcWFMLf1psjHU54CTQTDz74yAqPZoXCDnU7sxbf2d~muasM1EpTao-lXTLgrHQVl6AQzqoQVgha3Vpf5X2Nqi7boFutI6kxxNIVNdj1de7wAfWxa-5P43EE87wIQRcD3FKafukPG8CBuIBXJ8kqcJHMpebeYfPwk4NHehFiG2nRVMJxeOKyDcbkvPkxa2G2nD9NQfhbRL97k621nXrDFHsCuiH-~ViTkq87SgkrVt9ZFnmwbai6CLYlNb5HG6vsUGzcyg1AAR3T5K9a3IUF4fVfw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
R1
Psychiatry and Mental health
Vaccination/statistics & numerical data
Female
Mental Disorders/epidemiology
DOI:
10.1001/jamapsychiatry.2024.2339
Publication Date:
2024-08-21T22:41:59Z
AUTHORS (170)
ABSTRACT
ImportanceAssociations have been found between COVID-19 and subsequent mental illness in both hospital- and population-based studies. However, evidence regarding which mental illnesses are associated with COVID-19 by vaccination status in these populations is limited.ObjectiveTo determine which mental illnesses are associated with diagnosed COVID-19 by vaccination status in both hospitalized patients and the general population.Design, Setting, and ParticipantsThis study was conducted in 3 cohorts, 1 before vaccine availability followed during the wild-type/Alpha variant eras (January 2020-June 2021) and 2 (vaccinated and unvaccinated) during the Delta variant era (June-December 2021). With National Health Service England approval, OpenSAFELY-TPP was used to access linked data from 24 million people registered with general practices in England using TPP SystmOne. People registered with a GP in England for at least 6 months and alive with known age between 18 and 110 years, sex, deprivation index information, and region at baseline were included. People were excluded if they had COVID-19 before baseline. Data were analyzed from July 2022 to June 2024.ExposureConfirmed COVID-19 diagnosis recorded in primary care secondary care, testing data, or the death registry.Main Outcomes and MeasuresAdjusted hazard ratios (aHRs) comparing the incidence of mental illnesses after diagnosis of COVID-19 with the incidence before or without COVID-19 for depression, serious mental illness, general anxiety, posttraumatic stress disorder, eating disorders, addiction, self-harm, and suicide.ResultsThe largest cohort, the pre–vaccine availability cohort, included 18 648 606 people (9 363 710 [50.2%] female and 9 284 896 [49.8%] male) with a median (IQR) age of 49 (34-64) years. The vaccinated cohort included 14 035 286 individuals (7 308 556 [52.1%] female and 6 726 730 [47.9%] male) with a median (IQR) age of 53 (38-67) years. The unvaccinated cohort included 3 242 215 individuals (1 363 401 [42.1%] female and 1 878 814 [57.9%] male) with a median (IQR) age of 35 (27-46) years. Incidence of most outcomes was elevated during weeks 1 through 4 after COVID-19 diagnosis, compared with before or without COVID-19, in each cohort. Incidence of mental illnesses was lower in the vaccinated cohort compared with the pre–vaccine availability and unvaccinated cohorts: aHRs for depression and serious mental illness during weeks 1 through 4 after COVID-19 were 1.93 (95% CI, 1.88-1.98) and 1.49 (95% CI, 1.41-1.57) in the pre–vaccine availability cohort and 1.79 (95% CI, 1.68-1.90) and 1.45 (95% CI, 1.27-1.65) in the unvaccinated cohort compared with 1.16 (95% CI, 1.12-1.20) and 0.91 (95% CI, 0.85-0.98) in the vaccinated cohort. Elevation in incidence was higher and persisted longer after hospitalization for COVID-19.Conclusions and RelevanceIn this study, incidence of mental illnesses was elevated for up to a year following severe COVID-19 in unvaccinated people. These findings suggest that vaccination may mitigate the adverse effects of COVID-19 on mental health.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....